Alnylam Pharmaceuticals (ALNY) News
NASDAQ: ALNYHealth CareBiotechnology: Pharmaceutical PreparationsUSD
232.68+8.15 (+3.63%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
ALNY news summary
We found 5 recent headlines mentioning Alnylam Pharmaceuticals (ALNY): 3 in the past week and 4 in the past 30 days, most often from Nasdaq. For price context, ALNY is up 3.63% at $232.68. The most recent story, "Alnylam vs. Ionis: Here's the Better Bad-News Buy", was published by Nasdaq on Oct 10, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Alnylam Pharmaceuticals headlines
- Alnylam vs. Ionis: Here's the Better Bad-News BuyKey PointsAlnylam cut its full-year revenue guidance due to slower-than-expected sales for Amvuttra.NasdaqPFE, IONS, ALNY, AZN
- argenx Meets Primary Endpoint in Phase II Celiac Disease StudyARGX's FB102 achieves its primary endpoint in a phase II celiac disease study, paving the way for late-stage development despite a nearly 12% stock drop.NasdaqARGX, ALNY, AMRN, ALDX
- ARGX Stock Down on Stopping Late-Stage Autoimmune Disease Studyargenx shares tumble 12% after discontinuing its late-stage Sjogren's disease study, while positive FB102 data in celiac disease offer a contrasting pipeline development.NasdaqARGX, ALNY, CRSP
- Notable ETF Inflow Detected - TCAF, CNP, ALNY, KDPLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the T. Rowe Price Capital Appreciation Equity ETF (Symbol: TCAF) where we…NasdaqTCAF, CNP, ALNY, KDP
- TCAF, CNP, COR, ALNY: ETF Inflow AlertLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the T. Rowe Price Capital Appreciation Equity ETF (Symbol: TCAF) where we…NasdaqTCAF, CNP, COR, ALNY